Evaluation of Easym, a Clonotypic Mass Spectrometry Assay, and Euroflow Minimal Residual Disease Assessment in Multiple Myeloma

被引：0
|
作者：
Zhao, Jessie [1 ,2 ]
Khong, Tiffany T. [1 ,2 ]
Gorniak, Malgorzata [3 ]
Khaled, Abir [4 ]
McDonald, Zac [4 ]
Reynolds, John [1 ,2 ]
Wong, Daniel [1 ,2 ]
Bingham, Nicholas [1 ,2 ]
Johnston, Anna M. [5 ]
Motorna, Olga [6 ]
Murphy, Nicholas E. [5 ]
Quach, Hang [7 ]
Yang, Liqiang [4 ]
Spencer, Andrew [1 ,2 ]
机构：
[1] Alfred Hosp, Dept Malignant Haematol & Stem Cell Transplantat, Melbourne, Vic, Australia
[2] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic, Australia
[3] Alfred Hosp, Alfred Pathol, Melbourne, Vic, Australia
[4] Rapid Novor, Kitchener, ON, Canada
[5] Royal Hobart Hosp, Hobart, Tas, Australia
[6] Eastern Hlth, Melbourne, Vic, Australia
[7] St Vincents Hosp Melbourne, East Melbourne, Australia
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179742
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Comparison of EasyM, a clonotypic mass spectrometry assay, and EuroFlow minimal residual disease assessment in multiple myeloma
    Zhao, Jessie
    Khong, Tiffany
    Gorniak, Malgorzata
    Khaled, Abir
    Mcdonald, Zac
    Reynolds, John
    Mithraprabhu, Sridurga
    Bingham, Nicholas
    Lim, Suehli
    Wong, Daniel
    Johnston, Anna
    Motorna, Olga
    Murphy, Nicholas
    Quach, Hang
    Yang, Liqiang
    Spencer, Andrew
    HAEMATOLOGICA, 2025, 110 (03) : 764 - 767
  • [2] Clonotypic Mass Spectrometry with Easym Assay for Detection of Measurable Residual Disease in Multiple Myeloma
    Slade, Michael J.
    Khalid, Abir
    Fiala, Mark A.
    Liyasova, Mariya
    Zaydman, Mark A.
    McDonald, Zac
    Fortier, Julie M.
    Kelley, Sarah
    Crees, Zachary D.
    Schroeder, Mark A.
    Stockerl-Goldstein, Keith E.
    Yang, Liqiang
    Vij, Ravi
    BLOOD, 2022, 140 : 4376 - 4377
  • [3] Measurable Residual Disease Status By Clonotypic Mass Spectrometry with Easym Assay Predicts Outcomes Following Autologous Hematopoietic Cell Transplant in Multiple Myeloma
    Slade, Michael
    Khaled, Abir
    Fiala, Mark
    McDonald, Zac
    Liyasova, Mariya
    Fortier, Julie
    Zaydman, Mark
    Kelley, Sarah
    Crees, Zachary David
    Schroeder, Mark A.
    Stockerl-Goldstein, Keith
    Yang, Liqiang
    Vij, Ravi
    BLOOD, 2023, 142
  • [4] Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)
    Fan, Huishou
    Wang, Bing
    Shi, Lihui
    Pan, Ni
    Yan, Wenqiang
    Xu, Jingyu
    Gong, Lixin
    Li, Lingna
    Liu, Yuntong
    Du, Chenxing
    Cui, Jian
    Zhu, Guoqing
    Deng, Shuhui
    Sui, Weiwei
    Xu, Yan
    Yi, Shuhua
    Hao, Mu
    Zou, Dehui
    Chen, Xiequn
    Qiu, Lugui
    An, Gang
    CLINICAL CANCER RESEARCH, 2024, 30 (06) : 1131 - 1142
  • [5] Euroflow-Based Ultrasensitive NGF for the Evaluation of Bone Marrow Minimal Residual Disease in Multiple Myeloma
    Gaviria, Paula Tabares
    Schmiedgen, Katharina
    Dhanraj, Jayabhuvaneshwari
    Dagdeviren, Huesniye
    Wilnit, Amy
    Ulbrich, Maria
    Paiva, Bruno
    Kortuem, K. Martin
    Rasche, Leo
    Einsele, Hermann
    Beilhack, Andreas
    Waldschmidt, Johannes M.
    BLOOD, 2023, 142
  • [6] Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods
    Takeshi Yoroidaka
    Kentaro Narita
    Hiroyuki Takamatsu
    Momoko Fujisawa
    Shinji Nakao
    Kosei Matsue
    Scientific Reports, 11
  • [7] Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods
    Yoroidaka, Takeshi
    Narita, Kentaro
    Takamatsu, Hiroyuki
    Fujisawa, Momoko
    Nakao, Shinji
    Matsue, Kosei
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] The Utility of Mass Spectrometry in Defining Minimal Residual Disease in Treated Multiple Myeloma Patients
    Campbell, Lauren
    Lau, I-Jun
    Ramasamy, Karthik
    Sadler, Ross
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S144 - S145
  • [9] M-protein detection by mass spectrometry for minimal residual disease in multiple myeloma
    Guan, Lihua
    Su, Wei
    Zhong, Jian
    Qiu, Ling
    CLINICA CHIMICA ACTA, 2024, 552
  • [10] Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease
    Thoren, Katie L.
    SEMINARS IN HEMATOLOGY, 2018, 55 (01) : 41 - 43
12345